Mobile ECG Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Modality), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Mobile ECG Devices Market size was worth USD 3.01 Billion in 2025 and is expected to grow at a 11.6% CAGR between 2026 and 2035, surpassing USD 9.02 Billion by 2035. The industry revenue for 2026 is assessed at USD 3.33 billion.

• Base Year Value (2025): USD 3.01 Billion
• CAGR (2026-2035): 11.6%
• Forecast Year Value (2035): USD 9.02 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Mobile ECG Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 51.41% share in 2025 due to mature connected healthcare infrastructure, widespread remote cardiac monitoring, and strong integration of portable ECG devices into clinical and home-based care.
  • Asia Pacific is projected to grow at a 12.99% CAGR, supported by expanding digital health services, greater healthcare technology access, and rising demand for flexible cardiac monitoring beyond hospitals.

• Segment Momentum:

  • Hospitals and Diagnostic Centers accounted for 51.62% of the market in 2025 due to high cardiac assessment volumes, structured diagnostic workflows, and access to trained clinicians for reliable ECG evaluation.
  • Band devices are the fastest-growing modality because they enable continuous, wearable ECG monitoring during daily activities, offering greater convenience than intermittent handheld assessments.

• Market Expansion Drivers:

  • Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand.
  • Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking.
  • Expansion of telemedicine and home-based cardiac care accelerating device adoption.

• Leading Market Participants:

  Leading companies in the mobile ECG devices market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Medtronic plc (Ireland), iRhythm Technologies, Inc. (United States), Nihon Kohden Corporation (Japan), Omron Healthcare Co., Ltd. (Japan), AliveCor, Inc. (United States), Withings S.A. (France), EMAY Ltd. (China), Dr Trust (India).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 3.01 Billion
  • Projected Market Size: USD 9.02 Billion by 2035
  • Growth Forecasts: 11.6% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals and Diagnostic Centers (End-use) | Handheld (Modality)
  • Emerging Opportunity Segment: Homecare (End-use) | Band (Modality)

Market Growth Drivers and Industry Trends

Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand

As arrhythmias become more common and older patient populations require closer longitudinal observation, providers are shifting from episodic in-clinic testing toward monitoring models that capture cardiac events in daily life. This is strengthening demand for the mobile ECG devices market because intermittent symptoms often go undetected during short hospital visits, while portable ECG solutions allow physicians to extend surveillance beyond traditional care settings. The aging population also raises the volume of patients needing follow-up after diagnosis, medication adjustment, or cardiac procedures, pushing health systems and cardiology practices to use mobile ECG devices to triage risk, prioritize intervention, and manage recurring monitoring needs more efficiently.

Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking

Continuous ECG tracking is becoming more practical as sensors, consumer-friendly wearables, and app-based health platforms are integrated into a single monitoring workflow. In the mobile ECG devices market, this integration is influencing market adoption by reducing friction for both patients and clinicians: users can capture or stream rhythm data through familiar devices, while providers receive organized recordings that are easier to review, store, and share. The result is a shift in purchasing preference toward connected ECG solutions that fit into broader digital health ecosystems, encouraging market growth as interoperability and user convenience become decisive factors in device selection.

Expansion of telemedicine and home-based cardiac care accelerating device adoption

The expansion of virtual consultations and home-based care is changing how cardiac assessment is delivered, creating a stronger role for portable diagnostic tools that can function outside hospitals and specialty clinics. This is contributing to market size growth in the mobile ECG devices market because clinicians need reliable ECG data during remote encounters to evaluate symptoms, monitor treatment response, and decide whether escalation to in-person care is necessary. As care pathways increasingly include post-discharge monitoring and at-home chronic disease management, mobile ECG devices are being adopted as practical infrastructure for remote cardiology workflows rather than as stand-alone accessories.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing prevalence of cardiovascular diseases	4.50%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	High	Fast
Adoption of portable ECG devices in hospitals and clinics	4.00%	Medium term (2–5 yrs)	Europe, Asia Pacific (spillover: North America)	Medium	Moderate
Integration with telemedicine and remote patient monitoring	3.10%	Long term (5+ yrs)	North America, Europe (spillover: Asia Pacific)	Medium	Slow
Rising cardiac arrhythmia prevalence and aging population driving remote cardiac monitoring demand	2.10%	High	North America, Europe	High	Near Term
Integration of wearable technologies and mobile health platforms enabling continuous ECG tracking	1.80%	High	North America, Asia Pacific	High	Mid Term
Expansion of telemedicine and home-based cardiac care accelerating device adoption	1.50%	High	Asia Pacific, Europe	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 51.41% share of the mobile ECG devices market in 2025, reflecting the region’s established base of connected healthcare infrastructure, broad clinical familiarity with remote cardiac monitoring, and stronger integration of portable diagnostics into routine care pathways. Demand is supported in practice by higher use of ambulatory monitoring for arrhythmia detection, follow-up care, and home-based observation, allowing providers to incorporate mobile ECG devices into both hospital-led and outpatient workflows. The region’s position is also aided by the presence of mature digital health ecosystems and faster uptake of device-enabled monitoring models that fit existing care delivery and reimbursement structures.

Asia Pacific is projected to expand at a 12.99% CAGR over the forecast period, with growth in the mobile ECG devices market being propelled by widening access to healthcare technology, rising use of portable monitoring tools outside major hospital settings, and stronger adoption of digital health services across densely populated markets. The region’s acceleration is tied to practical needs on the ground, particularly the push to extend cardiac assessment into community clinics, home care, and remote patient management where conventional monitoring access can be uneven. As healthcare systems broaden their use of mobile and app-linked diagnostic tools, adoption is increasing in settings that require lower-cost, scalable, and more flexible cardiac monitoring options.

Key Country Insights

United States

Remote Cardiac Monitoring

The U.S. mobile ECG devices market is driven by expanding remote patient monitoring and digital health adoption. Healthcare providers increasingly integrate portable ECG solutions into chronic cardiac care, preventive screening, and virtual care programs.

Japan

Aging Care Solutions

Japan emphasizes mobile ECG devices that enable continuous cardiac monitoring for an aging population with growing cardiovascular care needs. Healthcare providers value compact, user-friendly systems that support early rhythm detection outside hospital settings.

South Korea

Digital Health Connectivity

South Korea encourages adoption of mobile ECG devices integrated with connected health platforms and telemedicine services. Manufacturers focus on AI-assisted analysis, wireless connectivity, and efficient data sharing with healthcare professionals.

Germany

Clinical Accuracy Focus

Germany prioritizes mobile ECG devices that deliver reliable diagnostic performance while integrating with established healthcare workflows. Demand is supported by physician confidence in validated monitoring technologies for outpatient cardiac assessment.

France

Preventive Cardiac Screening

France supports mobile ECG deployment across preventive cardiology and ambulatory monitoring programs. Healthcare providers increasingly utilize portable diagnostic tools to improve early detection and continuity of cardiovascular care.

Italy

Ambulatory Monitoring Expansion

Italy advances the use of mobile ECG devices across outpatient cardiology services and home-based patient monitoring. Clinical demand centers on practical, easy-to-use solutions that support long-term rhythm assessment and follow-up care.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals and Diagnostic Centers (Largest Segment) vs Homecare (Fastest-Growing Segment)

Hospitals and Diagnostic Centers held the leading position in the mobile ECG devices market in 2025, accounting for a 51.62% share. Their leadership is anchored in routine cardiac assessment volumes, broader access to trained clinicians, and the need for dependable ECG capture within structured diagnostic workflows. These settings remain the primary point of care for patients requiring immediate evaluation, follow-up testing, or confirmation of arrhythmias, which sustains consistent demand for mobile ECG devices across inpatient and outpatient environments.

Homecare is emerging as the fastest-growing end-use segment in the mobile ECG devices market as cardiac monitoring increasingly shifts closer to the patient. Growth is being influenced by the practical advantage of capturing ECG data outside clinical facilities, especially for ongoing observation, symptom-triggered recording, and patient convenience. Compared with facility-based use, homecare gains momentum from its ability to support more continuous and accessible monitoring without requiring repeated hospital or diagnostic center visits.

Modality Segment Analysis: Handheld (Largest Segment) vs Band (Fastest-Growing Segment)

By 2025, handheld devices represented the largest modality in the mobile ECG devices market with a 43.67% share. Their market leadership reflects a balance of portability, ease of use, and suitability for spot-check cardiac assessments across clinical and non-clinical settings. Handheld formats fit well into routine screening and rapid evaluation workflows, making them a practical choice where users need mobile ECG devices that are simple to deploy without the fixed constraints of larger systems.

Band devices are the fastest-growing modality in the mobile ECG devices market because they align with rising demand for more wearable and less intrusive monitoring formats. Their momentum comes from the ability to support ongoing ECG tracking during daily activity, which makes them increasingly attractive relative to handheld alternatives used mainly for intermittent readings. As monitoring needs move toward greater continuity and user convenience, band-based mobile ECG devices are seeing stronger adoption.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals and Diagnostic Centers, Ambulatory Care, Homecare	Hospitals and Diagnostic Centers	Homecare
Modality	Pen, Band, Handheld, Others	Handheld	Band

Competitive Landscape and Market Positioning

Major players in the mobile ECG devices market:

1. Koninklijke Philips N.V. (Netherlands)

2. GE HealthCare Technologies Inc. (United States)

3. Medtronic plc (Ireland)

4. iRhythm Technologies Inc. (United States)

5. Nihon Kohden Corporation (Japan)

6. Omron Healthcare Co. Ltd. (Japan)

7. AliveCor Inc. (United States)

8. Withings S.A. (France)

9. EMAY Ltd. (China)

10. Dr Trust (India)

Increasing demand for remote cardiac monitoring is driving the mobile ECG devices market, with continuous innovation in wearable technologies, wireless connectivity, and AI-assisted ECG interpretation. Product advancements are enabling earlier diagnosis and more convenient long-term cardiovascular monitoring.

Industry Development/News

Company Name	Date	Key Development
VivaLNK, Inc.	May-23	VivaLNK launched an updated multi-parameter wearable ECG patch designed to enable continuous 14-day livestream cardiac monitoring. The device is positioned to improve patient comfort while reducing administrative workload for clinical teams, supporting broader adoption of long-duration remote cardiac monitoring solutions in mobile ECG device applications.
InfoBionic.Ai	Aug-25	InfoBionic.Ai received FDA 510(k) clearance for its MoMe ARC 1-lead patch, introducing an extended-duration configuration for continuous ECG data collection. The clearance strengthens the company’s remote cardiac monitoring portfolio and supports expanded use in long-term arrhythmia detection and digital cardiac care workflows.
Clario	Jun-24	Clario obtained FDA 510(k) clearance for its SpiroSphere integrated with the wireless COR-12 ECG device, enhancing remote cardiac data capture capabilities in decentralized clinical trial settings. The development supports improved physiologic monitoring integration and expands Clario’s role in digital clinical research infrastructure.
Wellysis	Mar-24	Wellysis, a Samsung spin-off, launched a remote cardiac monitoring system in the U.S. in partnership with Artella Solutions. The initiative expands deployment of wearable ECG-enabled remote monitoring solutions, supporting broader adoption of connected cardiac care technologies in outpatient and remote healthcare environments.
Infobionic	Oct-23	Infobionic received FDA clearance for its next-generation MoMe ARC remote ECG monitoring solution designed for arrhythmia detection and chronic disease management. The clearance strengthens its position in virtual cardiac care by enhancing continuous monitoring capabilities and supporting expanded clinical use of remote diagnostic workflows.
SmartCardia	Sep-23	SmartCardia received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform enabling continuous monitoring for up to 14 days. The approval enhances its remote cardiac monitoring capabilities and supports broader adoption of multi-lead wearable ECG systems in ambulatory and clinical care environments.